An interventional study of Personalized patch template in Hypoplastic Left Heart Syndrome (HLHS) and Aortic Arch Hypoplasia, sponsored by The Hospital for Sick Children. Not yet recruiting at 1 site in Canada. Open to participants aged 0 Months to 2 Months. Per ClinicalTrials.gov, last updated 2025-08-01.
Sponsored by The Hospital for Sick Children · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Hypoplastic Left Heart Syndrome with a site in Canada — 4 open to participants now, 5 under way, 1 of them phase 3. Hypoplastic Left Heart Syndrome · Canada.
Among the 13 studies in Hypoplastic Left Heart Syndrome with a site in Canada, this one is the only one that started in 2025, is one of 5 with no phase, and was the 13th registered.
67 studies on the registry are indexed under Hypoplastic Left Heart Syndrome; 12 are open to participants now.
Browse Hypoplastic Left Heart Syndrome studies →4 of the 13 studies in Hypoplastic Left Heart Syndrome with a site in Canada are open now. Recruiting first, the newest first:
Queen Silvia Children's Hospital, Gothenburg, Sweden · Sites in Canada, United States, Austria and 5 more countries
Ages 23 wk–31 wk
McGill University Health Centre/Research Institute of the McGill University Health Centre · Sites in Canada
Ages 0 days–7 days
Children's Hospital Medical Center, Cincinnati · Sites in Canada, United States, United Kingdom
Ages up to 15 mo
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 9 Hypoplastic Left Heart Syndrome studies recruiting now, 3 set no upper age limit and 6 stop at 75 or younger; 9 take children under 18; none take healthy volunteers.
This study: 0 Months to 2 Months · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 1 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 30 is close to the median of 30 across 41 interventional studies indexed under Hypoplastic Left Heart Syndrome.
Median enrollment 28 across the 8 interventional studies, 187 across the 5 observational. Of the 6 that completed or were terminated, 1 (17%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 13 has an industry lead sponsor. The 8 most frequent:
The Hospital for Sick Children is the lead sponsor of 579 studies on the registry; 81 are open to participants now.
Of its 7 completed or terminated interventional studies of FDA-regulated products, 1 (14%) have results posted.
The Hospital for Sick Children has 3 studies filed under Hypoplastic Left Heart Syndrome — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 13 studies in Hypoplastic Left Heart Syndrome with a site in Canada, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Vascular Reconstruction is one of the most challenging areas of surgery, the surgeon has to create a completely watertight reconstruction without any narrowing or deformity that will restore normal flow characteristics, even at high pressures. Nowhere is this more challenging than in neonatal heart surgery where babies born with aortic arch narrowing or underdevelopment are one of the commonest life-threatening cardiovascular conditions.
Reconstruction not only has to recreate normal anatomy but also allow for subsequent growth and development.
Until now, surgical reconstruction depended on the surgeon's subjective assessment of the anatomy and a best estimate of patch shaping and design. New engineering techniques have enabled us to create 3D printed models of real hearts and then recreate the actual surgery on these models using a variety of engineered patches and different surgical techniques. These reconstructed models can now be placed in flow-testing rigs and undergo 4-dimensional flow imaging to provide high-fidelity velocity and shear force analysis that allow for precision design of the ideal geometry to give optimal flow.
This project will combine the skills of the largest team of neonatal heart surgeons in Canada, working with cardiac imaging experts, physicists and biomechanical engineers who are recognized as the world leaders in 3D printing technologies for congenital heart disease. Using a series of rigorous repeated tests and different designs we will define the ideal techniques and patch shapes and then translate this to real cases where a precision-shaped personalized patch can be created for each individual. Following up these babies as they grow with precision 3D scanning will show how these vessels are growing. Our mathematics-driven approach will make the surgery easier, shorter and more efficient. It will also provide more consistent surgical results among surgeons.
Aortic arch reconstruction complications can be prevented or minimalized by personalizing the surgical technique and patch through mathematical computer modeling and 3D printing.
This is a feasibility study on the use of graphical 3D printing and flow modelling in the creation of personalized patch templates for the Norwood procedure and aortic arch reconstruction.
Patients undergoing the Norwood procedure as part of standard of care will be approached for consent. Patients who consent to the study will undergo a pre-operative contrast CT scan to design simulation models and to identify the most ideal aortic arch configuration. 3D printing of the sterilizable template will be done after computer-aided design of bespoke surgical patches and will be based on pre-operative imaging and simulation. The sterilizable patch template will be used by the surgeon as a guide to fashioning the precise size and shape of the patch.
A research CT scan will be done post-operatively, prior to patient discharge. The post-op CT scan will be used to create a 3D printed model of the reconstructed aortic arch, This 3D printed model will then undergo 4D MRI scanning as part of the analysis.
Patients will be monitored and followed closely post-surgery. They will be assessed by routine post-operative tests including standard of care imaging at 4-6 months after surgery.
Clinical outcome assessment at 6-12 months after surgery will be measured.
This data will be compared to surgical outcomes of a historical cohort of patients who had traditional patches.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Using each participant's pre-operative imaging, the most ideal aortic arch configuration will be identified. This will be followed by simulation of mechanical effects on the adjacent structures by overlapping the designed aortic arch model on the participant's original images. Computer-aided design of the personalized patch template will then be completed and followed by 3D printing of the sterilizable, personalized patch template.
Procedure: Personalized patch template
The personalized, sterilizable patch template will be used as the surgeon's guide in fashioning the precise size and shape of the surgical patch.
Survival Rate (%): patient status (Alive/Dead)
Survival will be recorded based on patient status at the time of discharge (in-hospital), 30 days post-surgery, and at 1-year follow-up. The unit of measure will be the percentage of patients who remain alive at each of these time points.
Time frame: In hospital, at 30 days and at 1 year follow-up
Hemodynamic Stability: Inotrope Requirement (daily score)
A scale measuring the need for inotropic support, based on the number and type of inotropic medications required. Inotropic support will be quantified on a daily score (ranging from 0 to a maximum score depending on inotrope usage).
Time frame: Post-op Day 1: Initial assessment within 24 hours of surgery, Post-op Days 2-7: Daily assessments during the first week post-surgery, 1 month, 6 months, 1 year follow up: Evaluation of ongoing hemodynamic stability
Hemodynamic Stability: Blood pressure
Measured in mmHg using a standard non-invasive sphygmomanometer or an arterial catheter for continuous measurement in the ICU.
Time frame: Post-op Day 1: Initial assessment within 24 hours of surgery, Post-op Days 2-7: Daily assessments during the first week post-surgery, 1 month, 6 months, 1 year follow up: Evaluation of ongoing hemodynamic stability
Hemodynamic Stability: Heart Rate
Measured in beats per minute (bpm) using ECG or pulse oximeter.
Time frame: Post-op Day 1: Initial assessment within 24 hours of surgery, Post-op Days 2-7: Daily assessments during the first week post-surgery, 1 month, 6 months, 1 year follow up: Evaluation of ongoing hemodynamic stability
Hemodynamic Stability: Oxygen Saturations (SpO2)
Measured as a percentage (%) using a pulse oximeter.
Time frame: Post-op Day 1: Initial assessment within 24 hours of surgery, Post-op Days 2-7: Daily assessments during the first week post-surgery, 1 month, 6 months, 1 year follow up: Evaluation of ongoing hemodynamic stability
Need for Re-intervention or Additional Surgeries (%)
Patient status (Need for re-exploration, reoperation, or catheter-based interventions) measured by the percentage (%) of patients requiring additional surgical or catheter-based interventions.
Time frame: During hospitalization, at 1 Month, 6 Months, and 1 Year Follow-up
Incidence of Post-operative Complications (%)
Percentage (%) of patients with complications (e.g., renal dysfunction, infection, bleeding, metabolic distress)
Time frame: Post-op Days 1-3, Post-op days 4-7, Post Discharge (1 month, 6 months, 1 year)
Growth Parameters at Follow-up: Weight
Measurement of weight in kg
Time frame: At hospital discharge, at 1 Month, 6 Months, and 1 Year follow-up
Growth Parameters at Follow-up: Height
Measurement of height (cm)
Time frame: At hospital discharge, at 1 Month, 6 Months, and 1 Year follow-up
Growth Parameters at Follow-up: Oxygen saturation in %
Measurement of oxygen saturation SpO2 (%)
Time frame: At hospital discharge, at 1 Month, 6 Months, and 1 Year follow-up
Aortic Arch Dimensions (mm)
Aortic arch dimensions in mm (measured in different sections of the arch: ascending aorta, proximal, distal, isthmus).
Time frame: At pre-op, post-op day 1, and at follow-up: a 1 month, 6 months and 1 year post surgery
Flow velocity
Flow velocity in cm/s (measured using Doppler ultrasound or MRI 4D flow study).
Time frame: At pre-op, post-op day 1, and at follow-up: a 1 month, 6 months and 1 year post surgery
Cardiac Function (Ventricular Function and Valve Regurgitation) and Heart Structure (Atrial Septum Integrity)
Qualitative assessment of ventricular function, the atrial septum, tricuspid regurgitation and neo-aortic regurgitation through echocardiography
Time frame: At pre-op, post-op day 1, and at follow-up: a 1 month, 6 months and 1 year post surgery
Long-term Reintervention or Complications
Percentage (%) of patients requiring reintervention or experiencing complications
Time frame: At 1 month, 6 months, and 1 year follow-up
Incidence of Structural Issues (Pulmonary or Bronchial Compression) (%)
Percentage (%) of patients with left pulmonary artery compression, left main bronchus compression, or aortic arch tortuosity as measured by CT or MRI scans.
Time frame: At post-op Day 1 and at 1 month, 6 months and 1 year follow-up
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Sep 2025; primary completion for Jan 2028, 28 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hypoplastic Left Heart Syndrome →
The Hospital for Sick Children →